Approval · Notice of Compliance 22103 · 2019

IVOZFO: Notice of Compliance 22103

Issued May 1, 2019

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number: 22103
Date: May 1, 2019
Company: Verity Pharmaceuticals IncToronto, Ontario, Canada
Product type: Prescription Pharmaceutical
Submission: New Drug Submission (NDS)
Submission class: Priority

Products in this notice

Brand	DIN	Status today
IVOZFO	02488078	Approved
IVOZFO	02488086	Marketed
IVOZFO	02488094	Approved

Medicinal ingredients

FOSFOMYCIN SODIUM 2 G per VIAL
FOSFOMYCIN SODIUM 4 G per VIAL
FOSFOMYCIN SODIUM 8 G per VIAL